HUTCHMED DRC Net Income
| HCM Stock | USD 14.49 0.67 4.42% |
As of the 26th of February, HUTCHMED DRC retains the market risk adjusted performance of 0.1231, and Risk Adjusted Performance of 0.0394. HUTCHMED DRC technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out HUTCHMED DRC information ratio, value at risk, as well as the relationship between the Value At Risk and expected short fall to decide if HUTCHMED DRC is priced adequately, providing market reflects its last-minute price of 14.49 per share. Given that HUTCHMED DRC has jensen alpha of 0.0089, we strongly advise you to confirm HUTCHMED DRC's regular market performance to make sure the company can sustain itself next year.
HUTCHMED DRC Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 2.4286 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 34 M | 35.7 M | |
| Net Income From Continuing Ops | 34.4 M | 36.1 M | |
| Net Loss | -324.8 M | -308.5 M | |
| Net Income Per Share | 0.05 | 0.05 | |
| Net Income Per E B T | 0.96 | 1.00 |
HUTCHMED | Net Income | Build AI portfolio with HUTCHMED Stock |
Evaluating HUTCHMED DRC's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into HUTCHMED DRC's fundamental strength.
Latest HUTCHMED DRC's Net Income Growth Pattern
Below is the plot of the Net Income of HUTCHMED DRC over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in HUTCHMED DRC financial statement analysis. It represents the amount of money remaining after all of HUTCHMED DRC operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is HUTCHMED DRC's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in HUTCHMED DRC's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 37.73 M | 10 Years Trend |
|
Net Income |
| Timeline |
HUTCHMED Net Income Regression Statistics
| Arithmetic Mean | (38,221,355) | |
| Coefficient Of Variation | (285.45) | |
| Mean Deviation | 78,657,674 | |
| Median | 3,638,000 | |
| Standard Deviation | 109,101,873 | |
| Sample Variance | 11903.2T | |
| Range | 461.6M | |
| R-Value | (0.13) | |
| Mean Square Error | 12471.7T | |
| R-Squared | 0.02 | |
| Significance | 0.61 | |
| Slope | (2,876,283) | |
| Total Sum of Squares | 190451.5T |
HUTCHMED Net Income History
Other Fundumenentals of HUTCHMED DRC
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
HUTCHMED DRC Net Income component correlations
HUTCHMED Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for HUTCHMED DRC is extremely important. It helps to project a fair market value of HUTCHMED Stock properly, considering its historical fundamentals such as Net Income. Since HUTCHMED DRC's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of HUTCHMED DRC's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of HUTCHMED DRC's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Pharmaceuticals sector continue expanding? Could HUTCHMED diversify its offerings? Factors like these will boost the valuation of HUTCHMED DRC. Market participants price HUTCHMED higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every HUTCHMED DRC data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 16.333 | Earnings Share 2.65 | Revenue Per Share | Quarterly Revenue Growth (0.09) | Return On Assets |
Understanding HUTCHMED DRC requires distinguishing between market price and book value, where the latter reflects HUTCHMED's accounting equity. The concept of intrinsic value - what HUTCHMED DRC's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push HUTCHMED DRC's price substantially above or below its fundamental value.
Please note, there is a significant difference between HUTCHMED DRC's value and its price as these two are different measures arrived at by different means. Investors typically determine if HUTCHMED DRC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, HUTCHMED DRC's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
HUTCHMED DRC 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to HUTCHMED DRC's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of HUTCHMED DRC.
| 11/28/2025 |
| 02/26/2026 |
If you would invest 0.00 in HUTCHMED DRC on November 28, 2025 and sell it all today you would earn a total of 0.00 from holding HUTCHMED DRC or generate 0.0% return on investment in HUTCHMED DRC over 90 days. HUTCHMED DRC is related to or competes with Bausch Health, Perrigo Company, Ideaya Biosciences, Supernus Pharmaceuticals, Catalyst Pharmaceuticals, Scholar Rock, and Adaptive Biotechnologies. HUTCHMED Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immuno... More
HUTCHMED DRC Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure HUTCHMED DRC's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess HUTCHMED DRC upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.72 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 9.55 | |||
| Value At Risk | (2.68) | |||
| Potential Upside | 2.84 |
HUTCHMED DRC Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for HUTCHMED DRC's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as HUTCHMED DRC's standard deviation. In reality, there are many statistical measures that can use HUTCHMED DRC historical prices to predict the future HUTCHMED DRC's volatility.| Risk Adjusted Performance | 0.0394 | |||
| Jensen Alpha | 0.0089 | |||
| Total Risk Alpha | (0.17) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.1131 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of HUTCHMED DRC's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
HUTCHMED DRC February 26, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0394 | |||
| Market Risk Adjusted Performance | 0.1231 | |||
| Mean Deviation | 1.41 | |||
| Semi Deviation | 1.58 | |||
| Downside Deviation | 1.72 | |||
| Coefficient Of Variation | 2296.34 | |||
| Standard Deviation | 1.87 | |||
| Variance | 3.49 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | 0.0089 | |||
| Total Risk Alpha | (0.17) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.1131 | |||
| Maximum Drawdown | 9.55 | |||
| Value At Risk | (2.68) | |||
| Potential Upside | 2.84 | |||
| Downside Variance | 2.95 | |||
| Semi Variance | 2.51 | |||
| Expected Short fall | (1.45) | |||
| Skewness | 0.8442 | |||
| Kurtosis | 1.52 |
HUTCHMED DRC Backtested Returns
As of now, HUTCHMED Stock is very steady. HUTCHMED DRC holds Efficiency (Sharpe) Ratio of 0.0134, which attests that the entity had a 0.0134 % return per unit of volatility over the last 3 months. We have found twenty-seven technical indicators for HUTCHMED DRC, which you can use to evaluate the volatility of the firm. Please check out HUTCHMED DRC's risk adjusted performance of 0.0394, and Market Risk Adjusted Performance of 0.1231 to validate if the risk estimate we provide is consistent with the expected return of 0.0266%. HUTCHMED DRC has a performance score of 1 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.63, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, HUTCHMED DRC's returns are expected to increase less than the market. However, during the bear market, the loss of holding HUTCHMED DRC is expected to be smaller as well. HUTCHMED DRC presently retains a risk of 1.98%. Please check out HUTCHMED DRC expected short fall, and the relationship between the value at risk and day median price , to decide if HUTCHMED DRC will be following its current trending patterns.
Auto-correlation | 0.32 |
Below average predictability
HUTCHMED DRC has below average predictability. Overlapping area represents the amount of predictability between HUTCHMED DRC time series from 28th of November 2025 to 12th of January 2026 and 12th of January 2026 to 26th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of HUTCHMED DRC price movement. The serial correlation of 0.32 indicates that nearly 32.0% of current HUTCHMED DRC price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.32 | |
| Spearman Rank Test | 0.07 | |
| Residual Average | 0.0 | |
| Price Variance | 0.13 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
HUTCHMED Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, HUTCHMED DRC reported net income of 37.73 M. This is 88.94% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is 93.39% higher than that of the company.
HUTCHMED Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses HUTCHMED DRC's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of HUTCHMED DRC could also be used in its relative valuation, which is a method of valuing HUTCHMED DRC by comparing valuation metrics of similar companies.HUTCHMED DRC is currently under evaluation in net income category among its peers.
HUTCHMED DRC Current Valuation Drivers
We derive many important indicators used in calculating different scores of HUTCHMED DRC from analyzing HUTCHMED DRC's financial statements. These drivers represent accounts that assess HUTCHMED DRC's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of HUTCHMED DRC's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 5.7B | 2.6B | 3.1B | 2.5B | 2.2B | 3.3B | |
| Enterprise Value | 5.4B | 2.3B | 2.9B | 2.4B | 2.2B | 3.2B |
HUTCHMED DRC ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, HUTCHMED DRC's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to HUTCHMED DRC's managers, analysts, and investors.Environmental | Governance | Social |
HUTCHMED DRC Institutional Holders
Institutional Holdings refers to the ownership stake in HUTCHMED DRC that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of HUTCHMED DRC's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing HUTCHMED DRC's value.| Shares | Ubs Group Ag | 2025-06-30 | 64.4 K | Abn Amro Investment Solutions | 2025-06-30 | 63.9 K | Crossmark Global Holdings, Inc. | 2025-06-30 | 50.8 K | Neos Investment Management, Llc | 2025-06-30 | 42.6 K | Tema Etfs | 2025-06-30 | 42.6 K | Dekabank Deutsche Girozentrale | 2025-06-30 | 41.4 K | Citadel Advisors Llc | 2025-06-30 | 37.4 K | Two Sigma Investments Llc | 2025-06-30 | 27.6 K | Bnp Paribas Arbitrage, Sa | 2025-06-30 | 25 K | Schroder Investment Management Group | 2025-06-30 | 2.6 M | Allianz Asset Management Ag | 2025-06-30 | 924.5 K |
HUTCHMED Fundamentals
| Return On Equity | 0.47 | ||||
| Return On Asset | -0.0081 | ||||
| Profit Margin | 0.78 % | ||||
| Operating Margin | (0.01) % | ||||
| Current Valuation | 1.46 B | ||||
| Shares Outstanding | 171.9 M | ||||
| Shares Owned By Institutions | 3.06 % | ||||
| Number Of Shares Shorted | 315.47 K | ||||
| Price To Earning | 335.94 X | ||||
| Price To Book | 2.25 X | ||||
| Price To Sales | 4.52 X | ||||
| Revenue | 630.2 M | ||||
| Gross Profit | 53.76 M | ||||
| EBITDA | 14.11 M | ||||
| Net Income | 37.73 M | ||||
| Cash And Equivalents | 829.71 M | ||||
| Cash Per Share | 4.91 X | ||||
| Total Debt | 89.82 M | ||||
| Current Ratio | 3.18 X | ||||
| Book Value Per Share | 1.43 X | ||||
| Cash Flow From Operations | 497 K | ||||
| Short Ratio | 6.07 X | ||||
| Earnings Per Share | 2.65 X | ||||
| Target Price | 21.11 | ||||
| Number Of Employees | 1.78 K | ||||
| Beta | 0.52 | ||||
| Market Capitalization | 2.72 B | ||||
| Total Asset | 1.27 B | ||||
| Retained Earnings | (833.17 M) | ||||
| Working Capital | 689.99 M | ||||
| Current Asset | 187.47 M | ||||
| Current Liabilities | 96.7 M | ||||
| Net Asset | 1.27 B |
About HUTCHMED DRC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze HUTCHMED DRC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of HUTCHMED DRC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of HUTCHMED DRC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out To learn how to invest in HUTCHMED Stock, please use our How to Invest in HUTCHMED DRC guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Will Pharmaceuticals sector continue expanding? Could HUTCHMED diversify its offerings? Factors like these will boost the valuation of HUTCHMED DRC. Market participants price HUTCHMED higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every HUTCHMED DRC data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 16.333 | Earnings Share 2.65 | Revenue Per Share | Quarterly Revenue Growth (0.09) | Return On Assets |
Understanding HUTCHMED DRC requires distinguishing between market price and book value, where the latter reflects HUTCHMED's accounting equity. The concept of intrinsic value - what HUTCHMED DRC's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push HUTCHMED DRC's price substantially above or below its fundamental value.
Please note, there is a significant difference between HUTCHMED DRC's value and its price as these two are different measures arrived at by different means. Investors typically determine if HUTCHMED DRC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, HUTCHMED DRC's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.